FIELD: medicine.
SUBSTANCE: invention represents method of predicting progression of light cervical neoplasia in women of young and first period of mature age, which includes sampling of material to be analysed by scraping from cervix and its cytological analysis. In accordance with invention in case of detecting intraepithelial neoplasia of mild degree, constitutionally-anthropometric examination, in which somatotype is determined by dimensional variation level is additionally carried out, if microsomal or micromesosomal somatotype is identified, deeper immunocytochemical analysis of earlier sampled scrapings from cervix mucosa is realised to determine marker p16ink4α and in case of marker expression, severe neoplasia of cervix is predicted.
EFFECT: invention provides creation of practice-oriented method of predicting unfavourable course of cervical intraepithelial neoplasia due to integral evaluation of presence of human papilloma virus of highly-oncogenic type and oncodetector protein in case of cervical intraepithelial dysplasia, patient's personalised clinical and anthropometric status.
1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF PROGRESSION OF LOW-GRADE CERVICAL SQUAMOUS INTRAEPITHELIAL LESION WITH UNDERLYING HUMAN PAPILLOMAVIRUS INFECTION | 2021 |
|
RU2766719C1 |
| METHOD FOR USING IMMUNOLOGICAL MARKERS FOR PREDICTION OF PROLIFERATIONS OF CERVICAL INTRAEPITHELIAL NEOPLASIAS ASSOCIATED WITH PAPILLOMAVIRUS INFECTION | 2012 |
|
RU2520746C1 |
| METHOD FOR DIAGNOSING HUMAN PAPILLOMAVIRUS BY THE CONCENTRATION OF MOLECULAR MARKERS | 2021 |
|
RU2768491C1 |
| METHOD FOR PREDICTING THE RISK OF PROGRESSION OF RECURRENT CERVICAL INTRAEPITHELIAL NEOPLASIAS OF LOW DEGREE OF ONCOGENIC RISK ASSOCIATED WITH HUMAN PAPILLOMAVIRUS INFECTION | 2020 |
|
RU2748719C1 |
| METHOD FOR ASSESSING THE RISK OF PROGRESSION OF INTRAEPITHELIAL CERVICAL NEOPLASIA AND DEVELOPMENT OF CERVICAL CANCER BY DETERMINING THE LEVELS OF HUMAN MRNA GENES | 2015 |
|
RU2660360C2 |
| METHOD FOR TREATMENT OF CERVICAL INTRAEPITHELIAL GRADE I NEOPLASIA ASSOCIATED WITH HPV OF HIGH ONCOGENIC RISK, USING A CAVITATED SOLUTION OF PANAVIR | 2017 |
|
RU2682783C2 |
| METHOD FOR PREDICTING THE EFFECTIVENESS OF THE CONDUCTED TREATMENT OF I-II DEGREE CERVICAL INTRAEPITHELIAL NEOPLASIAS | 2021 |
|
RU2773799C1 |
| METHOD FOR PREVENTING PRECANCER RECURRENCE AND PRIMARY CERVICAL CANCER FOLLOWING ORGAN-PRESERVING TREATMENT BY DIAGNOSING AND TREATING HPV IN ANOGENITAL-OROPHARYNGEAL SPHERE IN SEXUAL PAIRS | 2020 |
|
RU2733934C2 |
| METHOD OF TREATING CERVICITIS ASSOCIATED WITH HUMAN PAPILLOMA VIRUS | 2018 |
|
RU2688326C1 |
| METHOD FOR PREDICTING THE RISK OF RECURRENCE IN HPV16-POSITIVE PATIENTS WITH SQUAMOUS INTRAEPITHELIAL HIGH-GRADE DISEASE ON THE BASIS OF DETERMINING THE PHYSICAL STATUS OF THE VIRUS | 2019 |
|
RU2719581C1 |
